These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 598035)

  • 21. [So-called cerebral gigantism].
    Raven EJ; Monnens L
    Midwives Chron; 1967 Sep; ():366-76. PubMed ID: 5182852
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cerebral gigantism].
    Schneider H; Vassella F
    Helv Paediatr Acta; 1971 Apr; 26(1):2-13. PubMed ID: 4930947
    [No Abstract]   [Full Text] [Related]  

  • 23. [The level of growth hormone in the blood serum in various diseases].
    Balabolkin MI; Gazetov BM
    Probl Endokrinol Gormonoter; 1966; 12(4):111-7. PubMed ID: 6012190
    [No Abstract]   [Full Text] [Related]  

  • 24. [Growth hormone (author's transl)].
    Grodecka B
    Postepy Biochem; 1975; 21(2):213-29. PubMed ID: 1153359
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of small doses of bromocriptine (Parlodel) on the serum level of growth hormone in acromegaly].
    Gáspár L; László F
    Orv Hetil; 1980 May; 121(20):1179-82. PubMed ID: 7413200
    [No Abstract]   [Full Text] [Related]  

  • 26. [CB-154 in the treatment of acromegaly: conclusion].
    Shizume K; Demura R
    Horumon To Rinsho; 1977 Dec; 25(12):1349-53. PubMed ID: 598044
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis: pituitary gigantism in a 2 1/2-year old child.
    Bhowmick SK; Rettig KR
    Clin Pediatr (Phila); 2008 Sep; 47(7):708-10. PubMed ID: 18724405
    [No Abstract]   [Full Text] [Related]  

  • 28. Bromocriptine in acromegaly.
    Thorner MO; Besser GM; Wass JA; Liuzzi A; Hall R; Muller EE; Chiodini PG
    N Engl J Med; 1981 Oct; 305(18):1092. PubMed ID: 7278927
    [No Abstract]   [Full Text] [Related]  

  • 29. [Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both].
    Barceló B; Pérez C; Dávila N; Lucas T; Salto L; Alcañiz J
    Med Clin (Barc); 1983 May; 80(17):735-41. PubMed ID: 6621120
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of bromocriptine (CB-154) in diabetes associated with acromegaly].
    Sakai Y; Nagasaka A; Makino H
    Horumon To Rinsho; 1977 Dec; 25(12):1323-6. PubMed ID: 598034
    [No Abstract]   [Full Text] [Related]  

  • 31. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1976 Aug; 115(33-34):1056-7. PubMed ID: 989744
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of metallothionein-human growth hormone fusion genes in transgenic mice results in disproportionate skeletal gigantism.
    Wolf E; Rapp K; Brem G
    Growth Dev Aging; 1991; 55(2):117-27. PubMed ID: 1938045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of growth disorders].
    Suárez M
    Minerva Pediatr; 1966 Oct; 18(30):1818-33. PubMed ID: 5995747
    [No Abstract]   [Full Text] [Related]  

  • 37. [Macroprolactinoma resistant to bromocriptine].
    López-Espinosa E; Ayala AR; Grimaldo J; Kunhardt J; Villanueva C
    Arch Invest Med (Mex); 1989; 20(1):1-8. PubMed ID: 2669670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 39. Prediction of response to bromocriptine in acromegaly.
    Atkinson AB; Trimble ER; Hadden DR; Sheridan B
    Ulster Med J; 1978; 47(1):73-8. PubMed ID: 653899
    [No Abstract]   [Full Text] [Related]  

  • 40. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L; Ljunghall S; Wide L; Boström H
    Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.